Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-006917
Filing Date
2025-09-10
Accepted
2025-09-10 16:10:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3230
  Complete submission text file 0001950047-25-006917.txt   4725
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Subject) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-26301 | Film No.: 251305991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4600 SOUTH SYRACUSE STREET SUITE 500 DENVER CO 80237
Business Address
Thompson Tommy G (Reporting) CIK: 0001324863 (see all company filings)

Type: 144